{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:08:40Z","timestamp":1793837320132,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jpeds.2021.10.063","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T16:25:44Z","timestamp":1636820744000},"page":"213-219.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase Deficiency"],"prefix":"10.1016","volume":"242","author":[{"given":"Patrice K.","family":"Held","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Bialk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Lasarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2021.10.063_bib1","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"issue":"Pt A","key":"10.1016\/j.jpeds.2021.10.063_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2016.06.015","article-title":"Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia","volume":"165","author":"Parsa","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jpeds.2021.10.063_bib3","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2021.10.063_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MED.0000000000000402","article-title":"Update on diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"25","author":"White","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jpeds.2021.10.063_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1749-6632.1985.tb14595.x","article-title":"Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska","volume":"458","author":"Pang","year":"1985","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpeds.2021.10.063_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jpeds.2021.10.063_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/ijns6030067","article-title":"Newborn screening for congenital adrenal hyperplasia: review of factors affecting screening accuracy","volume":"6","author":"Held","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2021.10.063_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpeds.2013.02.008","article-title":"Optimizing newborn screening for congenital adrenal hyperplasia","volume":"163","author":"White","year":"2013","journal-title":"J Pediatr"},{"issue":"4 Pt 1","key":"10.1016\/j.jpeds.2021.10.063_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1542\/peds.101.4.583","article-title":"Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia","volume":"101","author":"Therrell","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2021.10.063_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jpeds.2014.01.038","article-title":"Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants","volume":"164","author":"Sarafoglou","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.10.063_bib11","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1210\/jc.2004-2136","article-title":"Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight","volume":"90","author":"van der Kamp","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2021.10.063_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3476(97)70321-4","article-title":"Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels","volume":"130","author":"Allen","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.10.063_bib13","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1210\/jc.2002-021732","article-title":"Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value","volume":"88","author":"Olgem\u00f6ller","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2021.10.063_bib14","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1210\/jc.2018-02468","article-title":"Combined gestational age- and birth weight-adjusted cutoffs for newborn screening of congenital adrenal hyperplasia","volume":"104","author":"Pode-Shakked","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2021.10.063_bib15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1515\/jpem-2019-0140","article-title":"The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling","volume":"32","author":"Jiang","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2021.10.063_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/ijns6020037","article-title":"Newborn screening protocols and positive predictive value for congenital adrenal hyperplasia vary across the United States","volume":"6","author":"Speiser","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2021.10.063_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1373\/clinchem.2003.027193","article-title":"Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry","volume":"50","author":"Lacey","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.jpeds.2021.10.063_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1203\/PDR.0b013e3181aa3777","article-title":"Use of steroid profiling by UPLC-MS\/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience","volume":"66","author":"Schwarz","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2021.10.063_bib19","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/jc.2006-2890","article-title":"Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry","volume":"92","author":"Janzen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2021.10.063_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4155\/bio.16.6","article-title":"Determination of a steroid profile in heel prick blood using LC-MSMS","volume":"8","author":"Boelen","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpeds.2021.10.063_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/ijns5030033","article-title":"Wisconsin\u2019s screening algorithm for the identification of newborns with congenital adrenal hyperplasia","volume":"5","author":"Bialk","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2021.10.063_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/cen.14422","article-title":"Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand","volume":"94","author":"de Hora","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jpeds.2021.10.063_bib23","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2012.5281","article-title":"Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota","volume":"307","author":"Sarafoglou","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2021.10.063_bib24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000501396","article-title":"Congenital adrenal hyperplasia: time to replace 17OHP with 21-deoxycortisol","volume":"91","author":"Miller","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jpeds.2021.10.063_bib25","first-page":"537","article-title":"Radioimmunoassay for 21-deoxycortisol: clinical applications","volume":"108","author":"Gueux","year":"1985","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"Pt 1","key":"10.1016\/j.jpeds.2021.10.063_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/000456329403100110","article-title":"The application of a new highly-sensitive radioimmunoassay for plasma 21-deoxycortisol to the detection of steroid-21-hydroxylase deficiency","volume":"31","author":"Fiet","year":"1994","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jpeds.2021.10.063_bib27","first-page":"186","article-title":"A liquid chromatography\/tandem mass spectrometry profile of 16 serum steroids, including 21-deoxycortisol and 21-deoxycorticosterone, for management of congenital adrenal hyperplasia","volume":"1","author":"Fiet","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jpeds.2021.10.063_bib28","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jc.2015-1023","article-title":"Profiles of 21-carbon steroids in 21-hydroxylase deficiency","volume":"100","author":"Turcu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2021.10.063_bib29","doi-asserted-by":"crossref","first-page":"e4487","DOI":"10.1210\/clinem\/dgab464","article-title":"Second-tier testing for 21-hydroxylase deficiency in the Netherlands: a newborn screening pilot study","volume":"106","author":"Stroek","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2021.10.063_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1542\/peds.2008-2654","article-title":"Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system","volume":"123","author":"Jopling","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2021.10.063_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1983.tb09850.x","article-title":"Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism","volume":"304","author":"Bodeg\u00e5rd","year":"1983","journal-title":"Acta Paediatr Scand Suppl"},{"key":"10.1016\/j.jpeds.2021.10.063_bib32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archpedi.154.7.714","article-title":"The magnitude and challenge of false-positive newborn screening test results","volume":"154","author":"Kwon","year":"2000","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347621010635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347621010635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:11:27Z","timestamp":1758359487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347621010635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":32,"alternative-id":["S0022347621010635"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.10.063","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase Deficiency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.10.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}